In 2015, Gurocak et al. demonstrated that in Turkish children with overactive bladder, the inhibition of cholinergic activity with oxybutynin was efficient only in ADRB3:rs4994 TT homozygotes [23]. The gene discussed is ADRB3; the disease is overactive bladder.